CAC
Cowen and Company Portfolio holdings
AUM
$2.9B
This Quarter Return
+2.74%
1 Year Return
+104.28%
3 Year Return
+119.87%
5 Year Return
+632.2%
10 Year Return
–
AUM
$2.9B
AUM Growth
+$2.9B
(-20%)
Cap. Flow
-$857M
Cap. Flow
% of AUM
-29.56%
Top 10 Holdings %
Top 10 Hldgs %
65.12%
Holding
722
New
139
Increased
182
Reduced
153
Closed
142
Top Buys
| 1 |
Microsoft
MSFT
|
$121M |
| 2 |
Eli Lilly
LLY
|
$116M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$69.5M |
| 4 |
Palantir
PLTR
|
$19.5M |
| 5 |
Tesla
TSLA
|
$18.1M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$266M |
| 2 |
Avidity Biosciences
RNA
|
$210M |
| 3 |
Apple
AAPL
|
$191M |
| 4 |
Advanced Micro Devices
AMD
|
$107M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$91.7M |
Sector Composition
| 1 | Technology | 35.35% |
| 2 | Financials | 19.51% |
| 3 | Healthcare | 16.63% |
| 4 | Consumer Discretionary | 10.55% |
| 5 | Communication Services | 9.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
NVIDIA
NVDA
$4.24T
| $675M | 22.74% | 5,559,626 -245,742 | -4% | -$29.8M |
|
2
Coinbase
COIN
$78.2B
| $227M | 7.65% | 1,275,333 -213,642 | -14% | -$38.1M |
|
|
3
Meta Platforms (Facebook)
META
$1.86T
| $177M | 5.97% | 309,820 -463,835 | -60% | -$266M |
|
4
Amazon
AMZN
$2.44T
| $143M | 4.83% | 769,822 +90,736 | +13% | +$16.9M |
|
|
5
Microsoft
MSFT
$3.77T
| $141M | 4.74% | 327,257 +280,640 | +602% | +$121M |
|
6
PTC Therapeutics
PTCT
$3.92B
| $133M | 4.49% | 3,590,655 -165,814 | -4% | -$6.15M |
|
|
7
Apple
AAPL
$3.45T
| $122M | 4.11% | 523,959 -820,528 | -61% | -$191M |
|
|
8
Eli Lilly
LLY
$657B
| $116M | 3.89% | +130,399 | New | +$116M |
|
|
9
Tesla
TSLA
$1.08T
| $80.7M | 2.72% | 308,553 +69,169 | +29% | +$18.1M |
|
10
Tarsus Pharmaceuticals
TARS
$2.47B
| $72.3M | 2.43% | 2,197,385 | – | – |
|
|
11
Alphabet (Google) Class A
GOOGL
$2.57T
| $69.5M | 2.34% | +419,077 | New | +$69.5M |
|
12
Alibaba
BABA
$322B
| $67M | 2.26% | 631,199 +106,573 | +20% | +$11.3M |
|
|
13
Advanced Micro Devices
AMD
$264B
| $52M | 1.75% | 317,107 -650,124 | -67% | -$107M |
|
14
Stoke Therapeutics
STOK
$1.08B
| $39.9M | 1.34% | 3,244,498 -121,246 | -4% | -$1.49M |
|
15
Establishment Labs
ESTA
$1.2B
| $37.6M | 1.27% | 869,948 -70,000 | -7% | -$3.03M |
|
16
Energy Transfer Partners
ET
$60.8B
| $30.4M | 1.03% | 1,897,000 +70,000 | +4% | +$1.12M |
|
|
ANSC
17
Agriculture & Natural Solutions Acquisition Corp
ANSC
$471M
| $23.3M | 0.78% | 2,246,381 +272,702 | +14% | +$2.82M |
|
18
UroGen Pharma
URGN
$900M
| $22.8M | 0.77% | 1,796,589 -302,893 | -14% | -$3.85M |
|
19
Mercer International
MERC
$223M
| $22.3M | 0.75% | 3,300,000 | – | – |
|
|
AACT
20
Ares Acquisition Corporation II
AACT
$706M
| $21.3M | 0.72% | 1,963,091 -1,345,140 | -41% | -$14.6M |
|
21
Rocket Pharmaceuticals
RCKT
$354M
| $20.3M | 0.68% | 1,100,000 | – | – |
|
22
Sumitomo Mitsui Financial
SMFG
$105B
| $19.7M | 0.66% | 1,560,230 -1,240,500 | -44% | -$15.7M |
|
|
23
Palantir
PLTR
$372B
| $19.5M | 0.66% | +523,644 | New | +$19.5M |
|
24
Star Holdings Shares of Beneficial Interest
STHO
$115M
| $18.3M | 0.62% | 1,324,301 +4,705 | +0.4% | +$65.1K |
|
|
CCIX
25
Churchill Capital Corp IX Ordinary Shares
CCIX
$386M
| $18.2M | 0.61% | 1,813,000 +1,183,451 | +188% | +$11.9M |
|